Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients
Biochemical Genetics · 2024
DOI: 10.1007/s10528-023-10596-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Genetics, 2024. Verfasst von Yomna F Metwally und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt. fawzy.yomna89@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Interleukin-6, Interleukin-1beta, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Damiatta University.
Abstract (Originalsprache)
Lung cancer is a serious health and life issue, with the fastest-growing incidence and fatality rates worldwide. It is now clear that inflammation is a key factor involved in all aspects of carcinogenesis, notably lung cancer development. Genetic changes, including polymorphisms in inflammatory genes, are supposed to be a significant cause of increased lung cancer risk. The main idea of this research was to disclose the linkage between both IL-6 rs1800795 and IL-1β rs16944 variants and susceptibility to non-small-cell lung cancer (NSCLC) in Egyptians. This case–control design was composed of 127 cases and 138 controls, which were genotyped using the ARMS-PCR technique. To examine the NSCLC susceptibility under various genetic models, the odds ratio (OR) and 95% confidence intervals (CIs) were determined by logistic regression. Rs1800795 of the IL-6 gene was linked to higher odds of NSCLC under the allele model (adjusted, OR 2.28; 95% CI 1.2–4.33; p = 0.011). In the genetic models, IL-6 rs1800795 elevated the odds of NSCLC, while IL-1β rs16944 decreased the odds of NSCLC. Stratification analysis showed that IL-6 rs1800795 greatly increased the NSCLC risk in females and adenocarcinoma subtypes, whereas IL-1β rs16944 largely decreased the NSCLC risk for males, patients aged < 55, and nonsmokers. Regarding clinical data, the IL-6 variant was remarkably correlated with tumor size. This work primarily established that IL-6 and IL-1β variants have a great impact on NSCLC development in the Egyptian population; thus, it may be a supportive guide for earlier NSCLC prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt. fawzy.yomna89@gmail.com.
- Genetics Unit, Children Hospital, Mansoura University, Mansoura, Egypt.
- Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt.
- Oncology Department, Oncology Center, Mansoura University, Mansoura, Egypt.
Förderung
- Damiatta University
Zitieren
APA
Metwally, Y. F., Elsaid, A. M., Elsadda, R. R., Refaat, S., & Zahran, R. F. (2024). Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients. Biochemical Genetics. https://doi.org/10.1007/s10528-023-10596-2
Vancouver
Metwally YF, Elsaid AM, Elsadda RR, Refaat S, Zahran RF. Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients. Biochemical Genetics. 2024. doi:10.1007/s10528-023-10596-2
BibTeX
@article{Metwally2024,
author = {Metwally, Yomna F and Elsaid, Afaf M and Elsadda, Rana R and Refaat, Sherif and Zahran, Rasha F},
title = {Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients},
journal = {Biochemical Genetics},
year = {2024},
doi = {10.1007/s10528-023-10596-2}
}
EUVIMED